查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
中國的卵巢癌治療藥市場
市場調查報告書
商品編碼
1529143

中國的卵巢癌治療藥市場

Ovarian Cancer Treatment Drugs Markets in China
出版日期: | 出版商: Asia Market Information & Development Co. | 英文 272 Pages | 訂單完成後即時交付

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

過去十年，中國對卵巢癌藥物的需求快速成長。預計未來 10 年產量和需求將持續成長。二十多年來，在工業產值、進出口、居民消費、資本投資持續成長的推動下，中國經濟維持高速成長。本報告分析了中國經濟走勢、投資環境、產業動態、供需趨勢、產業產能、產業結構、行銷通路、主要市場參與者等。我們也估計市場表現數據（2013年、2018年、2023年）和長期預測（截至2028/2033年）。此外，我們還包括中國主要製造商的簡介。

我們在中國進行了初步和二次研究，以獲取最新的政府法規、市場資訊和行業數據。數據來自中國政府出版物、中文報紙和雜誌、行業協會、地方政府工業局、行業出版物和內部資料庫。對中國行業專家、大學教授和中國製造商進行了採訪。本報告應用經濟模型和定量方法來預測市場需求和行業趨勢。使用公制，金額以人民幣（人民幣，現價）或美元表示。

本公司的市場調查報告提供難以取得的市場資料與分析。現今中國擁有世界最大的市場。同時也擁有驚異的急速成長進口市場與對全球企業而言的商機。如果您想在中國擴大您的產業或銷售您的產品，本公司的調查報告將提供您不可或缺的中國市場相關洞察與預測。

目錄

第1章 簡介

  • 調查範圍·手法
  • 摘要整理

第2章 商務環境

  • 經濟展望
  • 主要經濟指標
  • 工業生產
  • 人口·勞動力
  • 直接投資
  • 對外貿易
  • 金融·稅務法規
  • 銀行系統和法規
  • 外匯
  • 稅制和關稅

第3章 卵巢癌治療藥產業的評估

  • 卵巢癌藥物產業的結構
  • 市場規模
  • 推動市場成長的因素
  • 卵巢癌治療藥物的銷售
  • 主要製造商的生產設施位置
  • 主要製造商的銷售和市場佔有率
  • 紫杉醇
  • 鉑類抗癌藥
  • 氟嘧啶
  • ?環類抗生素
  • 治療性抗體
  • 小分子藥物
  • 芳香?抑制劑（標靶治療）
  • 抗雌激素藥
  • 芳香?抑制劑（內分泌治療藥物）
  • LH-RH
  • 人員費用
  • 主要外資企業
  • 潛在進入者
  • 技術開發
  • 中國卵巢癌藥物價格

第4章 卵巢癌治療藥的生產·需求

  • 概要
  • 卵巢癌治療藥物的銷售
  • 化療藥物
  • 紫杉醇
  • 氟嘧啶
  • ?環類抗生素
  • 鉑類抗癌藥
  • 標靶治療
  • 治療性抗體
  • 小分子藥物
  • 芳香?抑制劑（標靶治療）
  • 內分泌治療藥物
  • 抗雌激素藥
  • 芳香?抑制劑（內分泌治療藥物）
  • LH-RH
  • 卵巢癌治療藥物進口量
  • 化療藥物
  • ?環類抗生素
  • 氟嘧啶
  • 紫杉醇
  • 鉑類抗癌藥
  • 標靶治療
  • 治療性抗體
  • 小分子藥物
  • 芳香?抑制劑（標靶治療）
  • 內分泌治療藥物
  • 抗雌激素藥
  • 芳香?抑制劑（內分泌治療藥物）
  • LH-RH
  • 價格趨勢

第5章 卵巢癌治療藥市場展望

  • 卵巢癌治療藥市場展望:概要
  • 政府的法規
  • 醫療·保險產業概要
  • 消費者支出趨勢
  • 人口趨勢
  • 醫療產業趨勢
  • 醫院數·病床數
  • 醫生數·醫生的體檢數量

第6章 市場進入流通管道

  • 中國市場概要
  • 中國的流通系統
  • 卵巢癌治療藥的流通管道
  • 交通·貨物運輸基礎設施
  • 通訊
  • 進入中國市場途徑
  • 授權合約
  • 專利權
  • 電子商務 (電子商務)
  • 公司和當地經銷商
  • 當地辦事處和中國的子公司
  • 獨資企業

第7章 卵巢癌治療藥製造廠商一覽

  • 卵巢癌治療藥製造商簡介一覽
Product Code: 826

China's demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2013, 2018 and 2023) and long-term forecasts through 2028 and 2033 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Ovarian Cancer Treatment Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Ovarian Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Producers' Sales Volume and Market Share
  • Paclitaxel
  • Platinum Anticancer Drugs
  • Fluoropyrimidines
  • Anthracycline Antibiotics
  • Therapertic Antibody
  • Small Molecules Drug
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Anti-estrogens
  • Aromatase Inhibitors (Endocrine Therapy Drug)
  • LH-RH
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development

IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Overview
  • Ovarian Cancer Treatment Drugs Sales Volume
  • Chemotherapeutic Drug
  • Paclitaxel
  • Fluoropyrimidines
  • Anthracycline Antibiotics
  • Platinum Anticancer Drugs
  • Targeted Therapy Drug
  • Therapertic Antibody
  • Small Molecules Drug
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Endocrine Therapy Drug
  • Anti-estrogens
  • Aromatase Inhibitors (Endocrine Therapy Drug)
  • LH-RH
  • Ovarian Cancer Treatment Drugs Import
  • Chemotherapeutic Drug
  • Anthracycline Antibiotics
  • Fluoropyrimidines
  • Paclitaxel
  • Platinum Anticancer Drugs
  • Targeted Therapy Drug
  • Therapertic Antibody
  • Small Molecules Drug
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Endocrine Therapy Drug
  • Anti-estrogens
  • Aromatase Inhibitors (Endocrine Therapy Drug)
  • LH-RH
  • Pricing Trend

V. OVARIAN CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Ovarian Cancer Treatment Drugs Markets Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKET ENTRY CHANNELS

  • China Market Entry Overview
  • China's Distribution System
  • Ovarian Cancer Treatment Drugs Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. OVARIAN CANCER TREATMENT DRUGS PRODUCER DIRECTORY

  • Ovarian Cancer Treatment Drugs Producer Profiles and Directory

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Chemotherapeutic Drug Sales Volume and Market Share by Drugs Classification
  • Targeted Therapy Drug Sales Volume and Market Share by Drugs Classification
  • Endocrine Therapy Drug Sales Volume and Market Share by Drugs Classification
  • Ovarian Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Location
  • Major Ovarian Cancer Treatment Drugs Producer Sales Volume and Market Share
  • Major Foreign Investments in China

IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Ovarian Cancer Treatment Drugs Sales Volume
  • Chemotherapeutic Drug Major Producer and Their Market Share
  • Chemotherapeutic Drug Sales Volume and Market Share by Drugs Classification
  • Chemotherapeutic Drug Major Producer and Their Market Share
  • Paclitaxel Major Producer and Their Market Share
  • Fluoropyrimidines Major Producer and Their Market Share
  • Anthracycline Antibiotics Major Producer and Their Market Share
  • Platinum Anticancer Drugs Major Producer and Their Market Share
  • Targeted Therapy Drug Major Producer and Their Market Share
  • Targeted Therapy Drug Sales Volume and Market Share by Drugs Classification
  • Therapertic Antibody Major Producer and Their Market Share
  • Small Molecules Drug Major Producer and Their Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Major Producer and Their Market Share
  • Endocrine Therapy Drug Sales Volume and Market Share by Drugs Classification
  • Endocrine Therapy Drug Major Producer and Their Market Share
  • Anti-estrogens Major Producer and Their Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Major Producer and Their Market Share
  • LH-RH Major Producer and Their Market Share
  • Ovarian Cancer Treatment Drugs Import

V. OVARIAN CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • Ovarian Cancer Treatment Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Output by Ownership
  • China's Imports and Exports

III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Chemotherapeutic Drug Market Share by Drugs Classification
  • Targeted Therapy Drug Market Share by Drugs Classification
  • Endocrine Therapy Drug Market Share by Drugs Classification
  • Ovarian Cancer Treatment Drugs Sales Volume

IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Ovarian Cancer Treatment Drugs Sales Volume
  • Chemotherapeutic Drug Sales Volume and Market Share
  • Chemotherapeutic Drug Sales Volume by Drugs Classification
  • Paclitaxel Sales Volume and Market Share
  • Fluoropyrimidines Sales Volume and Market Share
  • Anthracycline Antibiotics Sales Volume and Market Share
  • Platinum Anticancer Drugs Sales Volume and Market Share
  • Targeted Therapy Drug Sales Volume and Market Share
  • Targeted Therapy Drug Sales Volume by Drugs Classification
  • Therapertic Antibody Sales Volume and Market Share
  • Small Molecules Drug Sales Volume and Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Sales Volume and Market Share
  • Endocrine Therapy Drug Sales Volume and Market Share
  • Endocrine Therapy Drug Sales Volume by Drugs Classification
  • Anti-estrogens Sales Volume and Market Share
  • Progesterone Sales Volume and Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Sales Volume and Market Share
  • LH-RH Sales Volume and Market Share
  • Ovarian Cancer Treatment Drugs Import
  • Chemotherapeutic Drug Import and Market Share
  • Chemotherapeutic Drug Import by Drugs Classification
  • Paclitaxel Import and Market Share
  • Anthracycline Antibiotics Import and Market Share
  • Fluoropyrimidines Import and Market Share
  • Placlitaxel Anticancer Drugs Import and Market Share
  • Platinum Anticancer Drugs Import and Market Share
  • Targeted Therapy Drug Import and Market Share
  • Targeted Therapy Drug Import by Drugs Classification
  • Therapertic Antibody Import and Market Share
  • Small Molecules Drug Import and Market Share
  • Aromatase Inhibitors (Targeted Therapy Drug) Import and Market Share
  • Endocrine Therapy Drug Import and Market Share
  • Endocrine Therapy Drug Import by Drugs Classification
  • Anti-estrogens Import and Market Share
  • Progesterone Import and Market Share
  • Aromatase Inhibitors (Endocrine Therapy Drug) Import and Market Share
  • LH-RH Import and Market Share

VI. MARKETING STRATEGIES

  • China's Distribution Channel